-
Product Insights
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) – Drugs In Development, 2023
Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Drugs In Development, 2023’, provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological...
-
Product Insights
Muscle Invasive Bladder Cancer (MIBC) – Drugs In Development, 2023
Global Markets Direct’s, ‘Muscle Invasive Bladder Cancer (MIBC) - Drugs In Development, 2023’, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Muscle Invasive Bladder Cancer (MIBC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Bladder Carcinoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Bladder Carcinoma - Drugs In Development, 2023’, provides an overview of the Bladder Carcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bladder Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Muscle Invasive Bladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Muscle Invasive Bladder Cancer (MIBC) Clinical Trials Market Report Overview The MIBC clinical trial market research report provides an overview of Muscle Invasive Bladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Invasive Bladder Cancer. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
-
Sector Analysis
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Bladder Cancer Marketed and Pipeline Drugs Market Report Overview There are 13 marketed innovator therapies for bladder cancer, with an almost equal number of small molecules and biologics. The Bacillus Calmette-Guerin (BCG) vaccine is considered a gold-standard therapy in high-risk NMIBC (non-muscle-invasive bladder cancer) patients. The bladder cancer marketed and pipeline drugs market research report provides a data-driven overview of the current and future competitive landscape in bladder cancer therapeutics. This report includes an assessment of the disease epidemiology, leading...